HEPCINAT LP TABLETS

Get a Price/Quote

HEPCINAT LP TABLETS Specification

Origin of Medicine
India

Salt Composition
Ledipasvir 90 mg + Sofosbuvir 400 mg

Indication
Treatment of chronic hepatitis C genotype 1 infection

Pacakaging (Quantity Per Box)
28 tablets

Dosage Form
Tablet

Drug Type
Allopathic

Ingredients
Ledipasvir and Sofosbuvir

Physical Form
Tablets

Function
Antiviral agent for hepatitis C treatment

Recommended For
Chronic Hepatitis C Infection

Dosage
As directed by the physician

Dosage Guidelines
Take once daily with or without food as per medical advice

Suitable For
Adults

Quantity
28 tablets per box

Storage Instructions
Store below 30C, protected from moisture and sunlight

Prescription Required
Yes

Route of Administration
Oral

Trade Name
HEPCINAT-LP

Side Effects
May include fatigue, headache, nausea

Contraindications
Not recommended in patients with known hypersensitivity to any component

Marketed By
Natco Pharma

Tablet Shape
Oval

Colour
Yellow

Shelf Life
24 months

HEPCINAT LP TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About HEPCINAT LP TABLETS

Hepcinat Lp - Sofosbuvir & Ledipasvir

Specification :-

Brand Name : Hepcinat Lp
Content : Sofosbuvir Ledipasvir
Strength : Sofosbuvir 400mg And Ledipasvir 90 Mg
Packing : 1x28 Tablets
Type : Tablets
Uses : Hepatitis C
Manufactured by: Natco

Note :- Hepcinat LP Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug............

Powerful Combination Against Hepatitis C

HEPCINAT-LP harnesses the synergistic effects of Ledipasvir and Sofosbuvir to efficiently target chronic hepatitis C genotype 1 infection. Its oral administration simplifies therapy, empowering patients with once-daily dosing, and it helps reduce viral load for a better clinical prognosis.

Safety and Storage Guidelines

To maintain effectiveness, store HEPCINAT-LP tablets below 30C, shielded from moisture and sunlight. This medication is suitable only for adults and must be prescribed by a healthcare professional. Always adhere strictly to provided dosage guidelines for optimal results.

Convenient Packaging and Usage

HEPCINAT-LP is supplied in practical boxes containing 28 tabletsenough for nearly a month of therapy. The oval yellow tablets are easy to swallow, and their clear dosing regimen provides consistent and effective viral suppression with minimum disruption to daily life.

FAQs of HEPCINAT LP TABLETS:

Q: How should HEPCINAT-LP tablets be taken for optimal effectiveness?

A: HEPCINAT-LP tablets should be taken orally, once daily, with or without food, exactly as directed by your physician. Always take the medication at the same time each day to maintain consistent blood levels.

Q: What is the main benefit of using HEPCINAT-LP for hepatitis C?

A: The primary benefit of HEPCINAT-LP is its potent antiviral action against chronic hepatitis C genotype 1, which can lead to a reduction in viral load and improve liver health when taken regularly as prescribed.

Q: When is HEPCINAT-LP contraindicated?

A: HEPCINAT-LP is contraindicated in individuals with known hypersensitivity to Ledipasvir, Sofosbuvir, or any other component of the tablets.

Q: Where should HEPCINAT-LP tablets be stored?

A: Store HEPCINAT-LP tablets below 30C, in a dry place protected from moisture and sunlight, to preserve their potency throughout their 24-month shelf life.

Q: What side effects might occur during treatment with HEPCINAT-LP?

A: Common side effects may include fatigue, headache, and nausea. If you experience severe or persistent symptoms, contact your healthcare provider promptly.

Q: What processes are involved in obtaining HEPCINAT-LP?

A: A valid prescription from a physician is required to purchase HEPCINAT-LP. It is distributed, exported, and supplied by authorized traders and wholesalers in India.

Q: Is HEPCINAT-LP suitable for all patients with hepatitis C?

A: HEPCINAT-LP is specifically recommended for adults with chronic hepatitis C genotype 1 infection. Suitability must be assessed by a physician, considering any contraindications.

Tell us about your requirement